Vietnam Investment Review on MSN
Continuity Biosciences and Breakthrough T1D advance diabetes cell therapy
CARY, N.C. and NEW YORK, March 24, 2026 /PRNewswire/ -- Continuity Biosciences and Breakthrough T1D, the leading global type 1 diabetes (T1D) advocacy organization, today announced a strategic ...
Collaboration supports IND-enabling development and a planned Phase 1/2a first-in-human clinical study in type 1 diabetes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results